Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| EndoTheia | 2024 | Venture - Series Unknown | $500K | Nashville |
| ONL Therapeutics | 2024 | Series D | $65.0M | Ann Arbor |
| Inflammatix | 2024 | Series E | $57.0M | Burlingame |
| CoapTech | 2024 | Venture - Series Unknown | $7.1M | Baltimore |
| Kinoxis Therapeutics | 2024 | Series B | $9.5M | Melbourne |
| Magnetic Insight | 2024 | Series B | Undisclosed | Alameda |
| Spinogenix | 2024 | Venture - Series Unknown | $2.8M | San Diego |
| Envisagenics | 2024 | Series B | $25.0M | Long Island City |
| Raydiant Oximetry | 2024 | Series A | $7.5M | San Ramon |
| Genomenon | 2024 | Venture - Series Unknown | $5.5M | Ann Arbor |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | EndoTheia | Venture - Series Unknown | $500K | Nashville, United States |
| 27 | ONL Therapeutics | Series D | $65.0M | Ann Arbor, United States |
| 28 | Inflammatix | Series E | $57.0M | Burlingame, United States |
| 29 | CoapTech | Venture - Series Unknown | $7.1M | Baltimore, United States |
| 30 | Kinoxis Therapeutics | Series B | $9.5M | Melbourne, Australia |
| 31 | Magnetic Insight | Series B | Undisclosed | Alameda, United States |
| 32 | Spinogenix | Venture - Series Unknown | $2.8M | San Diego, United States |
| 33 | Envisagenics | Series B | $25.0M | Long Island City, United States |
| 34 | Raydiant Oximetry | Series A | $7.5M | San Ramon, United States |
| 35 | Genomenon | Venture - Series Unknown | $5.5M | Ann Arbor, United States |
EndoTheia is a medical equipment manufacturing firm that supplies the next generation of flexible endoscopic devices.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Inflammatix develops rapid immune system diagnostics to improve patient care and public health.
CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world.
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
Magnetic Insight is a biotechnology company that offers cellular imaging to measure the efficacy of cancer immunotherapies.
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.
AI-Driven Robotic Medical Technologies for Sleep Health
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
SentiAR is a digital health company that offers a holographic AR platform for intraprocedural clinical use.
Phenomix Sciences is a biotechnology company that specializes in biotech, life science, metabolomics, and genomics.
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.
ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Homecare Hub is an platform which has developed a marketplace that helps patients to find the high quality home care providers.
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Medical Device. The firm invests across 28 different industry categories.
Among tracked funding rounds, ProLynx received $70.0M in a Series A round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include EndoTheia, ONL Therapeutics, Inflammatix, CoapTech, Kinoxis Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors